Pearl H. Seo

734 total citations
18 papers, 563 citations indexed

About

Pearl H. Seo is a scholar working on Oncology, Molecular Biology and Geriatrics and Gerontology. According to data from OpenAlex, Pearl H. Seo has authored 18 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Geriatrics and Gerontology. Recurrent topics in Pearl H. Seo's work include Frailty in Older Adults (5 papers), Cancer survivorship and care (4 papers) and Cancer Treatment and Pharmacology (3 papers). Pearl H. Seo is often cited by papers focused on Frailty in Older Adults (5 papers), Cancer survivorship and care (4 papers) and Cancer Treatment and Pharmacology (3 papers). Pearl H. Seo collaborates with scholars based in United States, China and Singapore. Pearl H. Seo's co-authors include Harvey Jay Cohen, Jennifer Clarke, Carl F. Pieper, Katherine S. Garman, Bertrand Clarke, Elizabeth C. Clipp, Sally S. Ingram, Gustavo S. Montana, Marc E. Lippman and Catherine F. Welsh and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and JNCI Journal of the National Cancer Institute.

In The Last Decade

Pearl H. Seo

18 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pearl H. Seo United States 12 256 161 116 108 82 18 563
Pauline de Graeff Netherlands 17 262 1.0× 257 1.6× 138 1.2× 94 0.9× 131 1.6× 36 763
Hannah Woopen Germany 15 176 0.7× 118 0.7× 58 0.5× 63 0.6× 41 0.5× 56 861
Olumide B. Gbolahan United States 18 312 1.2× 118 0.7× 98 0.8× 221 2.0× 179 2.2× 65 766
Nitya Nathwani United States 12 186 0.7× 263 1.6× 39 0.3× 61 0.6× 27 0.3× 37 528
Nandini Menon India 13 256 1.0× 103 0.6× 88 0.8× 32 0.3× 234 2.9× 134 582
James E. Ward United States 12 360 1.4× 340 2.1× 48 0.4× 53 0.5× 100 1.2× 16 730
Marc Hilmi France 15 421 1.6× 171 1.1× 128 1.1× 49 0.5× 123 1.5× 34 716
Simran Padam United States 7 266 1.0× 38 0.2× 82 0.7× 113 1.0× 133 1.6× 16 572
Tyler F. Stewart United States 15 289 1.1× 123 0.8× 84 0.7× 16 0.1× 258 3.1× 64 600
Edwige Abeilard France 14 289 1.1× 308 1.9× 181 1.6× 15 0.1× 97 1.2× 17 651

Countries citing papers authored by Pearl H. Seo

Since Specialization
Citations

This map shows the geographic impact of Pearl H. Seo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pearl H. Seo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pearl H. Seo more than expected).

Fields of papers citing papers by Pearl H. Seo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pearl H. Seo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pearl H. Seo. The network helps show where Pearl H. Seo may publish in the future.

Co-authorship network of co-authors of Pearl H. Seo

This figure shows the co-authorship network connecting the top 25 collaborators of Pearl H. Seo. A scholar is included among the top collaborators of Pearl H. Seo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pearl H. Seo. Pearl H. Seo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Baca, Yasmine, Joanne Xiu, Joanita Figueredo, et al.. (2022). Impact of somatic SWI/SNF alterations on the genomic landscape of pancreatic ductal adenocarcinoma and response to PARP and immune checkpoint inhibitor therapy.. Journal of Clinical Oncology. 40(16_suppl). e16289–e16289. 1 indexed citations
2.
Valdes, Camilo, Pearl H. Seo, Nicholas F. Tsinoremas, & Jennifer Clarke. (2013). Characteristics of cross-hybridization and cross-alignment of expression in pseudo-xenograft samples by RNA-Seq and microarrays. PubMed. 3(1). 8–8. 4 indexed citations
3.
Montero, Alberto J., C. Marcela Díaz‐Montero, Yehuda E. Deutsch, et al.. (2011). Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer. Breast Cancer Research and Treatment. 132(1). 215–223. 90 indexed citations
4.
Ma, Qi, Xialin Liu, Pearl H. Seo, et al.. (2011). Will Periodic Intravenous Injections of Conditioned Bone Marrow Cells Effectively Reduce Atherosclerosis?. Antioxidants and Redox Signaling. 16(1). 85–91. 6 indexed citations
5.
Lobo, Christopher, Gilberto Lopes, Aurelio Castrellon, et al.. (2010). Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. Breast Cancer Research and Treatment. 123(2). 427–435. 68 indexed citations
6.
Iorns, Elizabeth, H. James Hnatyszyn, Pearl H. Seo, et al.. (2010). The Role of SATB1 in Breast Cancer Pathogenesis. JNCI Journal of the National Cancer Institute. 102(16). 1284–1296. 57 indexed citations
7.
Naeim, Arash, Arti Hurria, Arati V. Rao, et al.. (2010). The need for an aging and cancer curriculum for hematology/oncology trainees. Journal of Geriatric Oncology. 1(2). 109–113. 16 indexed citations
8.
Clarke, Jennifer, Pearl H. Seo, & Bertrand Clarke. (2010). Statistical expression deconvolution from mixed tissue samples. Bioinformatics. 26(8). 1043–1049. 53 indexed citations
9.
Glück, Stefan, et al.. (2008). Phase II study of nab-paclitaxel, bevacizumab, and gemcitabine for first-line therapy of patients with HER2-negative metastatic breast cancer (MBC). Journal of Clinical Oncology. 26(15_suppl). 1089–1089. 5 indexed citations
10.
Rao, Arati V., Arti Hurria, Gretchen Kimmick, Sandro O. Pinheiro, & Pearl H. Seo. (2008). Geriatric Oncology: Past, Present, Future. Journal of Oncology Practice. 4(4). 190–192. 12 indexed citations
11.
Sloane, Richard, et al.. (2006). Evaluation of agreement between physicians' notation of ‘no evidence of disease’ (NED) and patients' report of cancer status. Psycho-Oncology. 16(7). 668–675. 3 indexed citations
12.
Ingram, Sally S., Pearl H. Seo, Richard Sloane, et al.. (2005). The Association Between Oral Health and General Health and Quality of Life in Older Male Cancer Patients. Journal of the American Geriatrics Society. 53(9). 1504–1509. 30 indexed citations
13.
Bean, Gregory R., Victoria Scott, Xuhui Lee, et al.. (2005). Retinoic Acid Receptor-β2 Promoter Methylation in Random Periareolar Fine Needle Aspiration. Cancer Epidemiology Biomarkers & Prevention. 14(4). 790–798. 32 indexed citations
14.
Seo, Pearl H., Carl F. Pieper, & Harvey Jay Cohen. (2004). Effects of cancer history and comorbid conditions on mortality and healthcare use among older cancer survivors. Cancer. 101(10). 2276–2284. 22 indexed citations
15.
Seo, Pearl H., Anthony V. D’Amico, Jack A. Clark, et al.. (2004). Assessing a Prostate Cancer Brachytherapy Technique Using Early Patient-Reported Symptoms: A Potential Early Indicator for Technology Assessment?. PubMed. 3(1). 38–42. 9 indexed citations
16.
Seo, Pearl H., et al.. (2004). Aging and cancer.. PubMed. 2(7). 457–65. 15 indexed citations
17.
Garman, Katherine S., Carl F. Pieper, Pearl H. Seo, & Harvey Jay Cohen. (2003). Function in Elderly Cancer Survivors Depends on Comorbidities. The Journals of Gerontology Series A. 58(12). M1119–M1124. 80 indexed citations
18.
Ingram, Sally S., Pearl H. Seo, Robert E. Martell, et al.. (2002). Comprehensive Assessment of the Elderly Cancer Patient: The Feasibility of Self-Report Methodology. Journal of Clinical Oncology. 20(3). 770–775. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pauline de Graeff Breakdown of academic impact, for papers by Hannah Woopen Breakdown of academic impact, for papers by Olumide B. Gbolahan Breakdown of academic impact, for papers by Nitya Nathwani Breakdown of academic impact, for papers by Nandini Menon Breakdown of academic impact, for papers by James E. Ward Breakdown of academic impact, for papers by Marc Hilmi Breakdown of academic impact, for papers by Simran Padam Breakdown of academic impact, for papers by Tyler F. Stewart Breakdown of academic impact, for papers by Edwige Abeilard
Rankless by CCL
2026